Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK Profile”

Showing 9 of 0 results

Early research (Phase 1)Study completedNCT02710188
What this trial is testing

Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

Who this might be right for
Alzheimer's Disease
Nxera Pharma UK Limited 14
Testing effectiveness (Phase 2)Ended earlyNCT00522808
What this trial is testing

The PK, Safety and Antiviral Activity of A-831 in HCV Carriers

Who this might be right for
Chronic Hepatitis C
Arrow Therapeutics 36
Early research (Phase 1)Study completedNCT05118958
What this trial is testing

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 37
Early research (Phase 1)Study completedNCT02418793
What this trial is testing

A Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
OPKO Health, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT01054625
What this trial is testing

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Head and Neck Cancer
Genmab 31
Early research (Phase 1)Study completedNCT00651638
What this trial is testing

ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype

Who this might be right for
Healthy
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 17
Testing effectiveness (Phase 2)Ended earlyNCT03883607
What this trial is testing

Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non Alcoholic Steatohepatitis
Genfit 10
Testing effectiveness (Phase 2)Ended earlyNCT01737892
What this trial is testing

Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

Who this might be right for
Asthma
Amphastar Pharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT05478486
What this trial is testing

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
Godavari Biorefineries Limited 7

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation